Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
A private equity-backed buyer has acquired Omnicare, a pharmacy business in the United States, for $250m. Omnicare provides pharmacy services and medication fulfillment, supporting healthcare providers and patients through its retail and specialty pharmacy operations. The pharmacy acquisition supports healthcare M&A goals by expanding distribution capabilities and strengthening the buyer’s presence in the pharmacy segment. The divestiture acquisition follows CVS’s bankruptcy sale process as it streamlines its healthcare portfolio, with the deal valued at about $250m and expected to close after regulatory and court approvals.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026